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ABSTRACT 
Resveratrol, a member of the stilbene family, is a naturally occurring polyphenolic compound in grapes and other botanicals. It carries a 
potential to prevent or treat several chronic diseases, including cancers. Despite various promising health benefits, including chemopreventive 
and chemotherapeutic benefits against cancer, clinical translation of resveratrol is hampered due to its poor bioavailability, solubility and 
stability. Here we present the study to prepare nano-formulation of resveratrol for improving the resveratrol profile. Calcium phosphate loaded 
nanoresveratrol has been synthesized, characterized and its anti-proliferative effects were examined in a B16 murine melanoma cell line. The 
anti-cancer effects of nanoresveratrol were directly compared with free resveratrol and chemotherapy drug 5-FU. Nanoresveratrol induced 
apoptosis in B16 melanoma more efficiently as compared to resveratrol alone and 5 FU. A nuclear staining profile following Hoechst staining of 
B16 cells is indicative of apoptosis and shows that the anti-cancer effect of nanoresveratrol is due to apoptosis induction. Since antioxidant 
activity is a hallmark of resveratrol, we also measured the biochemical antioxidant activities of superoxide dismutase (SOD) and catalase 
antioxidant enzymes. We found that, concurrent with the anti-cancer activity, the antioxidant activity of nanoresveratrol increased. Collectively, 
these findings clearly show that nanoresveratrol is superior to free resveratrol in suppressing cell growth in B16 murine melanoma cell line, 
and that the anti-cancer activity is primarily through apoptosis induction. 
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1. INTRODUCTION 
Resveratrol (chemically: 3,5,4’-trihydroxystilbene) a 
member of stilbene family, is a naturally occurring 
polyphenolic compound present in grapes, berries, peanuts 
and red wine. It is a very well-known antioxidant and 
exhibits various biological effects including anticancer, 
antiangiogenic, immunomodulatory and cardioprotective 
activities [1,2,3]. Its beneficial potential in a variety of 
indications includes the chemoprotective & 
chemotherapeutic effects in several cancers [4]. Resveratrol 
has been reported to have a role in reducing the growth of 
human cancers originating from diverse organs/sites, 
including breast, cervix, ovary, uterine, kidney, liver, eye, 
bladder, thyroid, oesophagus, prostate, brain, lung, skin, 
gastric, colon, head and neck, bone and blood [5-13]. Several 
studies indicate that resveratrol shows multiple anticancer 
effects such as protection against tumour initiation and 
cancer progression, apoptosis, antioxidant, anti-
angiogenesis, anti-inflammatory, and antitumor migration 
[6-13]. Evidence show that resveratrol exerts its effects 
through different signalling pathways and several molecular 
players. Various studies report that resveratrol has a range 
of cellular effects, including cell cycle, invasion/metastasis, 
angiogenesis, apoptosis and autophagy. Several molecular 
players, such as BCL-2/BAX and AMPK, PI3K/AKT/mTOR, 
WNT, MEK, ERK pathways mediate resveratrol-induced 
cellular effects in different cancers [14]. However, the 
precise mechanisms remain to be delineated. There are 
several reports indicating the promising effects of 
resveratrol in treatment of skin cancer [15,16,17]. A recent 
report shows that resveratrol induces mitochondrial 
apoptosis in melanoma cell line through downregulating Bcl-
2, activating BAX leading to apoptosis [18]. Additionally, this 
report also showed that pyruvate kinase PKM2 played a role 
in apoptosis through interacting with Bcl-2.  
Despite widely established promising health benefits of 
resveratrol and its potential as a chemo preventive and 
chemotherapeutic agent in cancer based on in vitro and 
preclinical studies against several human cancers, its clinical 
translation remains challenging. Key challenges associated 
with the therapeutic application of resveratrol include poor 
solubility, stability and limited bioavailability [19,20]. 
Nanotechnology offers a wide range of innovative strategies 
to address the challenges associated with resveratrol. Plant 
metabolites can be incorporated into nano structures so that 
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they interact with biomolecules both inside the cell and on 
the surface of cells. With the coming of vast array of 
numerous novel nanosized delivery systems, it has paved a 
path for the development of various nano assemblies. These 
strategies have led to recent advances in formulation of 
nanoparticulate systems for various natural polyphenols 
targeted therapy and enhanced bioavailability with lowered 
adverse effects. Accumulating evidence reports a diverse 
kind of synthetic carriers or non-viral vectors for drug 
delivery. These carriers include liposome [21] lipid 
nanoparticles, [22] polymeric nanoparticles such as proteins 
[23] polymeric micelles [24] and hydrogels [25]. Calcium 
phosphate nanoparticles of size up to 100 nm in diameter 
have been used as carriers for the delivery of genes and 
drugs in animal cells with a relatively higher transfection 
efficiency compared to liposomal carriers [27, 28]. Improved 
formulations and drug delivery strategies can address the 
challenges associated with resveratrol [29-33]. In this study, 
we have synthesized and characterized calcium phosphate-
encapsulated nanoresveratrol and performed a comparative 
evaluation of the anti-cancer activity of nanoresveratrol, free 
resveratrol and clinically used chemotherapy drug 5-
Fluorouracil (5-FU). The ability of the free and encapsulated 
resveratrol to induce apoptosis in B16 melanoma cell line 
was evaluated. Since resveratrol is a well-known 
antioxidant, this activity was also examined.   
2. MATERIALS AND METHODS 
2.1 Chemicals 
Di-sodium hydrogen phosphate, Tris–HCl buffer, Buffer 
tablets (pH 4.0 and pH 8.0) and n-Hexane (AR grade) were 
obtained from Rankem (India). Calcium chloride, Gel loading 
dye and Ethidium bromide were obtained from ACROS 
Chem. (USA). The surfactant i.e. Sodium bis-(2-ethylhexyl) 
sulfosuccinate (AR grade) was obtained as 99% pure 
product from Sigma (USA).  
2.2 Cells and Reagents 
B16 murine melanoma cell line was a kind gift from the 
Department of Biotechnology, Jamia Hamdard. B16 cell line 
was cultured in RPMI-1640 with 10% Fetal bovine serum 
(Gibco-BRL, Grand Island, NY, USA) at 37˚C under 5% CO2 
humidified atmosphere. Resveratrol, Propidium Iodide, 
Hoechst 33342 and 5-Flurouracil were purchased from 
Sigma. 
2.3 Synthesis of Calcium Phosphate loaded 
Nanoresveratrol 
Nanoresveratrol loaded Calcium phosphate (CaP) 
nanoparticles were prepared in the aqueous core of an AOT 
(Aerosol-OT)/hexane/water reverse micellar system 
followed by the procedure described in the literature with 
some modifications [34]. In a typical set, 25 ml of 0.1 M AOT 
solution in hexane was prepared into which 70 µl aqueous 
solution of 1.36 M Calcium chloride and 50 µl stock solution 
of  resveratrol was added with continuous stirring for 12 
hours to form reverse micelle A. In another set  of  25 ml of 
0.1 M AOT/hexane solution, 50 µl of 0.2 M Tris–HCl buffer 
(pH 7.4) and 70 µl aqueous solution of 0.35 M Na2HPO4 was 
added with continuous stirring for 12 hours to form reverse 
micelle B. A calculated amount of excess water was added to 
each of the reverse micelles to make a total volume of added 
water to 250 ml in order to adjust Wo, i.e. the molar ratio of 
water to surfactant, to 10. Stirring was continued until both 
the reverse micelles A and B will become optically clear. 
Reverse micelle B, were then, added to reverse micelle A at 
an extremely slow rate with continuous stirring. The 
resulting mixture was further stirred for another 12 hours 
under the above cold conditions. The nanoparticles were 
found to remain dispersed at least for 24 h at room 
temperature after which the particles start settling at the 
bottom. Five ml of absolute ethanol (99.9% v/v) was added 
to break the reverse micelles into oil and aqueous phases. 
The particles were then separated by centrifugation of the 
aqueous phase at 12000 rpm. The particles were collected 
and dispersed in 95% v/v ethanol by sonication in a water 
bath sonicator. The ethanol solution was again centrifuged, 
and the particles were collected. Finally, the pelleted 
nanoparticles were dispersed in 5ml double distilled water 
by sonication for 15 min to prepare a clear dispersion. The 
dispersed nanoparticles were dialyzed overnight using a 12 
kD cut off dialysis membrane bag. After dialysis, the 
resultant solution was lyophilized to get the dry sample. 
2.4 Electron Microscopy 
Size and shape of the nanoparticles was characterized 
through negative staining of the nanoparticles [35,36] 
followed by observation under a transmission electron 
microscope (Morgnani). Measurements were made using a 
computerized image analyzer and average size of the 
nanoparticles was noted. 
2.5 Dynamic Light Scattering 
DLS was used to determine the particle size distribution of 
the synthesized nanoparticles. The Malvern Zetasizer 
3000HS was used to determine the size, size distribution and 
zeta potential of CaP nanoparticles at 25°C.1mg of the 
nanoparticles was dispersed in 2ml distilled water. Size and 
zeta potential were measured at 1.34 refractive index and 
0.2 absorbance. The size distribution obtained from photon 
correlation spectroscopy (PCS) is based on the intensity of 
scattered light. 
2.6 X-ray Diffraction Studies 
Crystalline characteristics of the particles was studied by X-
ray diffraction (XRD) studies. XRD were carried out on a 
Bruker D8 advance X-ray diffractometer using Ni-filtered Cu-
Kα radiation. Normal scans were typically having a step of 
0.02° with step time of 1sec over the range of 2θ=5-60°. Two 
mg of lyophilized nanoparticles were used for XRD analysis. 
2.7 Cell Toxicity Studies 
Equal number of cells were seeded and grown on cover slips 
in 6-well and 12 well plates (TPP, Switzerland) containing 
serum-free medium until they were sub-confluent. 
Resveratrol loaded calcium phosphate nanoparticles were 
used for the cell toxicity study. The concentrated 
nanoparticles were diluted in sterile autoclaved water. 
Nanoparticles at desired concentration were added to the 
cell culture. The cells were then incubated with the 
nanoparticles for 6h and 12h respectively. In the control 
group, cells were not treated with nanoparticles but were 
incubated for the same time periods. The cells were also 
treated with the same concentration of 5-Fluorouracil. 
Before terminating the culture, 500µl of the culture 
supernatant was collected from each well for further 
biochemical assays. The cells were then incubated for 15 
minutes with the fluorescent stains Hoechst 33342 at a 
working dilution of 5mM and propidium iodide at a final 
concentration of 50µg/ml to discriminate dead and live cells. 
Hoechst is a nuclear stain that labels the nuclei blue and it is 
routinely used to assess apoptosis [37,38]. A characteristic 
feature of a cell undergoing apoptosis is chromatin 
condensation and the apoptotic cells appear strong bright 
blue, while normal healthy cells appear uniform blue. 
Hoechst 33342 can enter intact cells without need for cell 
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membrane permeabilization which helps in the 
identification of early apoptotic cells.  
PI was then added to discriminate the early apoptotic 
population from the background of dead or very late 
apoptotic cells. PI can enter only those cells in which the cell 
membrane has been damaged as in dead cells or very late 
apoptotic cells. The cells were then washed in PBS three 
times for 5 minutes each and the cover slips were mounted 
on slides with 10% glycerol in PBS. The cells were 
immediately observed under an upright fluorescent 
microscope (Nikon Eclipse 600) using 488nm and 350nm 
filters. Images were captured using an Olympus DP-71 
digital camera mounted on the microscope. Ten different 
fields were captured at 40X and cell counts were taken 
within each microscopic field to get statistically significant 
counts for apoptotic cells and viable cells. PI-stained cells 
were also counted to count dead cells. The apoptotic cells 
were quantitated as a percentage of the total cell count.  
2.8 DNA Fragmentation Assay 
Briefly, after completion of the experimental protocol, the 
cells were scraped using a cell scraper (TPP) and collected in 
1.5 ml Eppendorf tubes. Lysis buffer (55µl volume) was 
added to each tube, followed by incubation of each sample 
for 20 minutes on ice. The tubes were centrifuged at 12,000g 
for 30 minutes at 4°C. The supernatant was collected, and 
DNA was isolated by routine phenol-chloroform extraction 
and cold ethanol precipitation. The DNA was quantitated, 
and equal quantities of DNA were dissolved in 30µl 
deionised water containing RNAse and 5µl loading buffer 
and kept for 30 minutes at 37°C. The samples were loaded 
on a 2% agarose gel containing ethidium bromide with 
molecular weight marker on the outer lane. After running 
the samples, the gel was observed under UV light in a 
transilluminator. 
2.9 Biochemical Assays 
Biochemical assays were carried out for studying the 
oxidative stress levels of  B16 cells after incubation with the 
nanoparticles. Endogenous antioxidant levels of Superoxide 
dismutase (SOD) and catalase (CAT) were determined in the 
cell culture supernatants as reported previously [39] and 
briefly described below. 
2.9.1 SOD Assay: A total volume of 100 μl culture 
supernatant was added to Sodium pyrophosphate buffer 
(pH-8.3) followed by addition of 0.1 ml of 186 μM Phenazine 
methosulphate, 0.3 ml of 300 mM Nitroblue tetrazolium and 
0.2 ml of 780 μM NADH. Reaction mixture was incubated for 
90 sec. at 30°C and stopped the reaction by adding 1.0 ml of 
glacial acetic acid. 4.0 ml of n-butanol was then added and 
centrifuged at 3,000 × g for 10 min. The absorbance of 
organic layer was measured at 560 nm. 
2.9.2 Catalase Assay: Briefly, 50 μl culture supernatant was 
added to a 3.0 ml cuvette that contained 1.95 ml of 50 mM 
phosphate buffer (pH-7.0). Then 1.0 ml of 30 mM hydrogen 
peroxide was added and changes in absorbance were 
measured for 30 sec. at 240 nm at an interval of 15 sec.  
3. RESULTS AND DISCUSSION 
Synthesis of Calcium phosphate loaded nanoresveratrol was 
performed as described above. Structures of the synthesized 
formulation were characterized by TEM, DLS & X Ray 
crystallography. The characterized nanoresveratrol was 
evaluated for the cell toxicity against B16 melanoma cell line 
though PI staining, apoptosis induction through DNA 
condensation and fragmentation studies, and antioxidant 
activity using SOD and Catalase assays.    
3.1 Physical Characterization of Nanoparticles-
Transmission Electron Microscopic (TEM)  
Size and morphology of the nanoparticles were determined 
by TEM as follows: one drop of the aqueous dispersion of 
CaP nanoparticles followed by one drop of 1% 
phosphotungstic acid were put on a formvar coated copper 
grid (1% solution of formvar was prepared in spectroscopic 
grade chloroform) and then air dried in a vacuum desiccator. 
The dried grid was examined under JEOL JEM 2000 EX 200 
model electron microscope unit at All India Institute of 
Medical Sciences (AIIMS), New Delhi, India. 
 
Fig 1(a)                     Fig 1(b) 
Figure1. TEM images of Calcium Phosphate 
Nanoparticles a) loaded with resveratrol; b) void 
nanoparticles. Resveratrol loaded calcium phosphate 
nanoparticles and void calcium phosphate nanoparticles 
revealed that the particles were mostly below 50 nm 
diameters and with spherical morphology. 
 
In our study we prepared CaP nanoparticles in the reverse 
micelles of Wo=10 and the size of nanoparticles ranging 
between 15-35 nm with average size around 20nm 
diameter, as shown in Fig 1. The TEM picture of Resveratrol 
loaded calcium phosphate nanoparticles and void calcium 
phosphate nanoparticles revealed that the particles were 
mostly below 50 nm diameters and with spherical 
morphology.  
The nanoparticles were prepared according to the present 
protocol at Wo=10. The size of the nanoparticles can be 
controlled not only by Wo but also by temperature and 
stirring time. In our experiment the entire synthetic protocol 
was performed in the cold room at 4ºC and the stirring was 
done for 12hrs. Higher temperature and longer duration of 
stirring, however, increase the particle size accordingly. 
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3.2 Dynamic Light Scattering Studies 
The TEM result was further confirmed by measuring the size 
of aqueous dispersed particles using Malvern Zetasizer 
3000HS. DLS studies revealed the size range of 15-32nm 
with maximum population of 20-25nm size particles (Fig 2). 
The size distribution obtained from photon correlation 
spectroscopy (PCS) is based on the intensity of scattered 
light. The average size of the nanoparticles was found to be 
marginally different from that obtained by electron 
microscopy.
 
 
Figure 2. Dynamic Light Scattering experiment showing size and size distribution of loaded CaP nanoparticles.  The size 
range of 15-32nm with maximum population of 20-25nm size particles 
 
3.3 X-Ray Diffraction Studies 
X-Ray diffraction studies were performed to study the 
crystalline characteristics of Calcium phosphate 
nanoparticles. Diffractograph of resveratrol loaded calcium 
phosphate nanoparticles synthesized at 4°C are crystalline in 
nature (Fig. 3). 
 
 
Figure 3. Powder XRD pattern of Resveratrol loaded Calcium Phosphate Nanoparticles. A characteristic peak of 2θ=31.8 
degree showed the formation of hydroxyapatite [Ca10(PO4)6(OH)2] crystals. 
 
3.4 Anticancer Activity 
To determine the effect of the characterized nanoparticles 
on B16 cell survival, we performed different studies to 
examine the anti-cancer effect of resveratrol. These studies  
included cytotoxicity, DNA condensation, and DNA 
fragmentation assays. 
3.4.1 Cytotoxicity  
To determine the cytotoxic effect of nanoresveratrol on B16 
cells, propidium iodide staining was performed. Resveratrol, 
nanoresveratrol and 5-FU were directly compared for their 
cytotoxic effects. Void nanoparticles were found to be 
biocompatible with B16 cells as indicated by reduced 
cytotoxicity. Nanoresveratrol proved to be more cytotoxic 
than resveratrol and 5-FU ( Fig 4). 
 
Figure 4. B16 cells treated or untreated with 
resveratrol, nanoresveratrol or 5-FU were stained with 
PI. Uptake of PI indicates cytotoxicity. Nanoresveratrol 
showed maximum cytotoxicity. 
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3.4.2 Apoptosis  
Next, we determined the ability of nanoresveratrol to induce 
DNA condensation and DNA fragmentation in B16 cell line. 
3.4.2.1 DNA Condensation: To assess DNA condensation, 
cells gown on cover slips, were treated with nanoparticles 
and stained with nuclear stain Hoechst, as described in 
Methods section. It was observed that the resveratrol loaded 
nanoparticles induced DNA condensation in B16 cells, 
indicative of apoptosis. In comparison, B16 cells treated with 
control void nanoparticles showed uniform staining (Fig 5). 
Furthermore, based upon the nuclear staining, apoptosis 
induced by nanoresveratrol was higher than in cells treated 
with free resveratrol. Apoptosis in both cases was time-
dependent with a higher level seen at 12h versus 6h. 
 
 
Fig 5 (a)                          Fig 5 (b) 
Figure 5.  Hoechst staining: a) B16 cells treated with void nano particles showed uniform blue staining with Hoechst. b) B16 cells 
treated with nanoresveratrol showed bright blue staining with Hoechst. 
 
3.4.2.2 DNA Fragmentation: Fragmentation of DNA is a 
hallmark of apoptosis during which the fragmented DNA 
appears as a ladder. To assess DNA fragmentation, we 
carried out a DNA fragmentation assay to see the apoptotic 
effect of nanoresveratrol on B16 cells (Fig.6). Assay was 
performed after treatment of cells with different agents and 
controls. Post-treatment, DNA was extracted from B16 cells 
and electrophoresed to see the characteristic “DNA 
laddering” typical of apoptotic cells. 
 
Figure 6. DNA Fragmentation Assay; Lane-1 (DNA Marker), 
Lane-2 (B16 cell lines), Lane-3 (Resveratrol), Lane-4 (5-
fluorouracil), Lane-5 (Nanoresveratrol) 
Cells incubated with the nanoresveratrol and 5-FU showed 
DNA laddering when compared to DNA from control cells 
(Fig.6;Lane 2). In addition, resveratrol treatment did not 
induce a strong ladder formation (lane 3), indicating modest 
apoptosis. In direct comparison with resveratrol, 
nanoresveratrol induced a clear DNA ladders indicating 
robust apoptosis. In addition, 5-FU also induced DNA 
fragmentation. Overall, this experiment clearly shows that 
calcium phosphate-encapsulated nanoresveratrol induces a 
robust apoptosis in melanoma cells.  
Collectively all the above-mentioned studies show that 
calcium phosphate-encapsulated nanoresveratrol induces a 
potent pro-apoptotic effect in B16 melanoma cells. These 
studies further establish that the nanoresveratrol is superior 
to resveratrol with respect to anti-cancer effects. 
Nanoresveratrol therefore represents a candidate 
formulation to confirm these data in vivo models of the 
disease. 
3.5 Antioxidant Activity 
Resveratrol is a well-established antioxidant. In addition to 
examining the anti-cancer activities of resveratrol and 
nanoresveratrol, we directly compared their antioxidant 
activities through measurement of SOD and Catalase, which 
are two major antioxidant enzymes (Fig.7). Void-nano 
particles showed minimal to effect on these activities, as 
expected. Both SOD and Catalase activities were increased 
upon treatment with nanoresveratrol. Nanoresveratrol 
showed increase in antioxidant activities as compared to 
free resveratrol.   
 
Figure 7. SOD and Catalase activity of Resveratrol, 
Nanoresveratrol and 5-FU. Nanoresveratrol showed 
increased SOD and catalase activity 
Accumulating literature shows that resveratrol influences 
several biological processes. Resveratrol may help in the 
treatment of various diseases by various molecular and 
cellular mechanisms [5-14].  It is worth mentioning that 
antioxidant activity is associated with resveratrol but may 
not be required for its anti-cancer effects. However, 
antioxidant activity is a good indicator of the resveratrol 
activity. Our data clearly show that nanoresveratrol has 
superior anti-cancer and antioxidant activities as compared 
to free resveratrol. 
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4. CONCLUSION 
In conclusion, we report here the synthesis and 
characterization of calcium phosphate encapsulated 
nanoresveratrol and determined the anti-cancer activity of 
nanoresveratrol in B16 murine melanoma cell line. We have 
observed that calcium phosphate nanoresveratrol shows a 
remarkably higher anti-cancer activity in B16 murine 
melanoma cell line as compared to resveratrol. The findings 
of the study indicate that nano formulation displays a 
superior efficacy as compared to free resveratrol warranting 
a further evaluation through in vivo models. To the best of 
our knowledge this is the first report showing the anticancer 
activity of calcium phosphate loaded nanoresveratrol in B16 
murine melanoma cell line. 
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